Balanced news tone
News Sentiment
VMD sentiment intelligence
Viemed Healthcare Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
76/100 classification confidence.
directly relevant articles
high-authority source matches
+2.4% over one week, +17.8% over four weeks, trend active, and materially above fair value.
As Q2 earnings kick off, these mega-cap healthcare stocks earn an A+ for profitability (XLV:NYSEARCA)
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Understanding Momentum Shifts in (VMD)
This article analyzes momentum shifts in Viemed Healthcare Inc. (VMD), indicating strong sentiment across all horizons and significant upside potential as no resistance levels remain. It details three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—t
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 18 Jun 2026 15:00
- Source
- Stock Traders Daily
Viemed Healthcare Inc (VMD) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Viemed Healthcare Inc (VMD), outlining its major shareholders and institutional holdings. It provides a breakdown of shareholder types, institutional holding trends from 2023Q4 to 2026Q1, and recent shareholder activity with chang
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 11:40
- Source
- TradingKey
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jun 2026 07:00
- Source
- StockStory
VMD - Viemed Healthcare Inc Stock Price and Quote
This page provides a comprehensive overview of Viemed Healthcare Inc (VMD) stock, including its latest closing price, key financial metrics, performance indicators, and recent news and analyst ratings. It details the company's market capitalization, income, sales, and various fin
- Tone
- Positive 64/100
- Event
- Analyst action
- Published
- 12 Jun 2026 11:10
- Source
- Finviz
Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- The Motley Fool
As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive Play
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Investopedia
Viemed Healthcare (VMD) Edges Higher, Testing Key Resistance Area - Diamond Pattern
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- dars.gov.et
Viemed Healthcare (Nasdaq: VMD) shareholders approve directors, pay and expanded 2024 LTIP
Viemed Healthcare shareholders approved key proposals at their Annual General and Special Meeting, including the election of all seven director nominees with strong support. They also backed a second amendment to the 2024 Long Term Incentive Plan, increasing reserved common share
- Tone
- Positive 60/100
- Event
- Market update
- Published
- 04 Jun 2026 20:09
- Source
- Stock Titan
VMD Financials: Revenue Breakdown, Margins & Competitor Comparison
This article analyzes the financial performance of Viemed Healthcare Inc (VMD), focusing on its profitability margins and comparing them to competitors like CYH and BTMD. VMD maintains a gross margin of 56.27%, with an operating margin of 6.27% and a net margin of 3.60%. The comp
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jun 2026 23:03
- Source
- Intellectia AI
VieMed Healthcare posts June 2026 investor deck with strong 2025 results and 2026 guidance
VieMed Healthcare (VMD) has released its investor deck for June 2026 presentations, highlighting record 2025 results and strong Q1 2026 momentum. The company reported $270.3M net revenue and $61.4M Adjusted EBITDA for 2025, with Q1 2026 showing continued growth in revenue and pat
- Tone
- Positive 90/100
- Event
- Earnings
- Published
- 02 Jun 2026 21:03
- Source
- TradingView
Viemed Healthcare (VMD) touts 28% 2025 growth, strong cash flow and 2026 guidance
Viemed Healthcare reported robust financial performance in 2025, including $270 million in net revenue (up 28% year-over-year) and $28 million in free cash flow, alongside strong guidance for 2026 with projected net revenues of $312–$320 million. The company emphasizes its divers
- Tone
- Positive 75/100
- Event
- Earnings
- Published
- 02 Jun 2026 21:03
- Source
- Stock Titan
VMD - Viemed Healthcare Inc Short Interest
This article provides a detailed financial overview of Viemed Healthcare Inc (VMD), including its current stock price, market capitalization, key financial ratios, and short interest data. It covers various performance metrics such as EPS, sales growth, insider and institutional
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jun 2026 19:39
- Source
- Finviz
Discipline and Rules-Based Execution in VMD Response
This article provides key findings for Viemed Healthcare Inc. (NYSE: VMD), highlighting a near-term strong sentiment transitioning to a long-term positive bias with a mid-channel oscillation pattern. It outlines an exceptional short setup for VMD and presents three distinct AI-ge
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 27 May 2026 12:22
- Source
- Stock Traders Daily
Viemed Healthcare (VMD) Shows Strength: Up 1.56% as Shares Test Key Resistance Zone - Call Spread Alert
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- DonanımHaber
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
Viemed Healthcare (VMD) Q1 Net Margin Stays Near 5% And Tests Bullish Profit Narratives
Viemed Healthcare (VMD) reported Q1 2026 revenue of US$75.4 million and EPS of US$0.07, maintaining a net margin near 5%. While the company has seen 21.2% trailing earnings growth, its steady quarterly EPS and reliance on government reimbursement for a significant portion of its
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 20 May 2026 17:09
- Source
- Sahm
Viemed Healthcare: Maintaining 'Buy' Rating Post Q1 On Improving Capital Efficiency
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 18 May 2026 07:00
- Source
- Seeking Alpha
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 14:27
- Source
- TMX Newsfile
Viemed Healthcare Q1 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 08:18
- Source
- MarketBeat
Viemed Healthcare, Inc. Q1 2026 Earnings Call Summary
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 12:30
- Source
- Moby
Viemed (VMD) Q1 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- The Motley Fool
Viemed Q1 2026 Results: Revenue Up 28%, Guidance Raised
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 May 2026 21:05
- Source
- ACCESS Newswire
Viemed Healthcare Announces First Quarter 2026 Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 May 2026 21:00
- Source
- ACCESS Newswire
Viemed Healthcare, Inc. (VMD) Q1 Earnings Miss Estimates
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- Market source
GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- StockStory
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
3 Healthcare Stocks That Fall Short
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- StockStory
Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- Seeking Alpha
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source